Skip to main content
. 2018 Nov 20;5:180263. doi: 10.1038/sdata.2018.263

Table 1. Baseline demographics and clinical data of studied ADNI subjects as determined at baseline.

  CN (n = 226) MCI (n = 392) AD (n = 188) p-value
APOE- Apolipoprotein E; MMSE- Mini–Mental State Examination; ADAS-Cog 13 Alzheimer’s Disease Assessment Scale cognitive scale, 13-item version. P-values are based on Chi-square test for APOE status and Kruskal-Wallace for all other variables. P-values were not corrected for multiple testing        
Age (years) 75.5 (72.2-78.4) 75.1 (70.1-80.4) 75.8 (70.8-80.5) 0.29
Gender (% Male) 47.8% 35.4% 47.6% 0.0019
APOE ε4 (%) 26.5% 53.3% 66.1%  <0.0001
MMSE 29.0 (29.0-30.0) 27.0 (26.0-28.0) 23.0 (22.0-25.0)  <0.0001
ADAS-Cog13 9.33 (6.0-12.3) 18.3 (14.7-23.0) 28.5 (23.7-34.0)  <0.0001